Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Community
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • Vax-Unvax: Let The Science Speak Home › Citations

    Chapter 11

    This is a listing of all citations in this chapter.

    31

    James G. Donahue et al., “Association of Spontaneous Abortion with Receipt of Inactivated Influenza Vaccine Containing H1N1pdm09 in 2010-11 and 2011-12,” Vaccine 35, no. 40 (2017): 5314–5322, doi:10.1016/j.vaccine.2017.06.069.

    32

    James G. Donahue et al., “Inactivated Influenza Vaccine and Spontaneous Abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15” Vaccine 37 (2019): 6673-6681, doi:10.1016/j.vaccine.2019.09.035.

    33

    James G. Donahue et al., “Inactivated Influenza Vaccine and Spontaneous Abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15” Vaccine 37 (2019): 6673-6681, doi:10.1016/j.vaccine.2019.09.035.

    34

    James G. Donahue et al., “Inactivated Influenza Vaccine and Spontaneous Abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15” Vaccine 37 (2019): 6673-6681, doi:10.1016/j.vaccine.2019.09.035.

    35

    Alberto Donzelli, “Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring,” International Journal of Environmental Research and Public Health 16, no. 22 (2019): 4347, doi:10.3390/ijerph16224347.

    36

    Milagritos Tapia et al., “Maternal Immunisation with Trivalent Inactivated Influenza Vaccine for Prevention of Influenza in Infants in Mali: A Prospective, Active-controlled, Observer-blind, Randomised Phase 4 Trial.” The Lancet Infectious Diseases 16, no. 9 (2016): 1026–1035. doi:10.1016/S1473-3099(16)30054-8.

    37

    Alberto Donzelli, “Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring,” International Journal of Environmental Research and Public Health 16, no. 22 (2019): 4347, doi:10.3390/ijerph16224347.

    38

    Alberto Donzelli, “Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring,” International Journal of Environmental Research and Public Health 16, no. 22 (2019): 4347, doi:10.3390/ijerph16224347.

    39

    Alberto Donzelli, “Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring,” International Journal of Environmental Research and Public Health 16, no. 22 (2019): 4347, doi:10.3390/ijerph16224347.

    40

    Milagritos Tapia et al., “Maternal Immunisation with Trivalent Inactivated Influenza Vaccine for Prevention of Influenza in Infants in Mali: A Prospective, Active-controlled, Observer-blind, Randomised Phase 4 Trial.” The Lancet Infectious Diseases 16, no. 9 (2016): 1026–1035. doi:10.1016/S1473-3099(16)30054-8.

    41

    Milagritos Tapia et al., “Maternal Immunisation with Trivalent Inactivated Influenza Vaccine for Prevention of Influenza in Infants in Mali: A Prospective, Active-controlled, Observer-blind, Randomised Phase 4 Trial.” The Lancet Infectious Diseases 16, no. 9 (2016): 1026–1035. doi:10.1016/S1473-3099(16)30054-8.

    42

    Alberto Donzelli, “Influenza Vaccination for All Pregnant Women? So Far the Less Biased Evidence does not Favour It,” Human Vaccines and Immunotherapeutics 15, no. 9 (2019): 2159-2164, doi:10.1080/21645515.2019.1568161.

    43

    Alberto Donzelli, “Influenza Vaccination for All Pregnant Women? So Far the Less Biased Evidence does not Favour It,” Human Vaccines and Immunotherapeutics 15, no. 9 (2019): 2159-2164, doi:10.1080/21645515.2019.1568161.

    44

    Alberto Donzelli, “Influenza Vaccination for All Pregnant Women? So Far the Less Biased Evidence does not Favour It,” Human Vaccines and Immunotherapeutics 15, no. 9 (2019): 2159-2164, doi:10.1080/21645515.2019.1568161.

    45

    Lisa M. Christian et al., “Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women,” Vaccine 29, no. 48, (2011): 8982–8987, doi:10.1016/j.vaccine.2011.09.039.

    46

    Lisa M. Christian et al., “Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women,” Vaccine 29, no. 48, (2011): 8982–8987, doi:10.1016/j.vaccine.2011.09.039.

    47

    Lisa M. Christian et al., “Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women,” Vaccine 29, no. 48, (2011): 8982–8987, doi:10.1016/j.vaccine.2011.09.039.

    48

    Lisa M. Christian et al., “Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women,” Vaccine 29, no. 48, (2011): 8982–8987, doi:10.1016/j.vaccine.2011.09.039.

    49

    Lisa M. Christian et al., “Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women,” Vaccine 29, no. 48, (2011): 8982–8987, doi:10.1016/j.vaccine.2011.09.039.

    50

    Cristopher S. Price et al., “Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobulins and Risk of Autism,” Pediatrics 126, no. 4 (2010): 656–664, doi:10.1542/peds.2010-0309.

    51

    Cristopher S. Price et al., “Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobulins and Risk of Autism,” Pediatrics 126, no. 4 (2010): 656–664, doi:10.1542/peds.2010-0309.

    52

    Cristopher S. Price et al., “Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobulins and Risk of Autism,” Pediatrics 126, no. 4 (2010): 656–664, doi:10.1542/peds.2010-0309.

    53

    US Food and Drug Administration, Fluvirin®: Package Insert, (Summit, NJ: Seqirus USA Inc., Revised 2017).

    54

    Cristopher S. Price et al., “Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobulins and Risk of Autism,” Pediatrics 126, no. 4 (2010): 656–664, doi:10.1542/peds.2010-0309.

    55

    Cristopher S. Price, Anne Robertson and Barbara Goodson, “Thimerosal and Autism Technical Report,” Abt Associates 1, (2009).

    56

    Cristopher S. Price, Anne Robertson and Barbara Goodson, “Thimerosal and Autism Technical Report,” Abt Associates 1, (2009).

    57

    Elyse O. Kharbanda et al., “Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes,” JAMA 312, no. 18 (2014): 1897–1904, doi:10.1001/jama.2014.14825.

    58

    Elyse O. Kharbanda et al., “Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes,” JAMA 312, no. 18 (2014): 1897–1904, doi:10.1001/jama.2014.14825.

    59

    Elyse O. Kharbanda et al., “Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes,” JAMA 312, no. 18 (2014): 1897–1904, doi:10.1001/jama.2014.14825.

    60

    Elyse O. Kharbanda et al., “Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes,” JAMA 312, no. 18 (2014): 1897–1904, doi:10.1001/jama.2014.14825.